Dainippon Sumitomo Acquires Sepracor

The US leads BMI's global Pharmaceuticals & Healthcare Business Environment Ratings with a score of 72.4 out of 100. It is the world's largest market for medicines, with a well-established regulatory regime and an extremely pro-industry socio-political system. Accordingly, all the major drugmakers have a presence in the country.

To read the full article, please choose one of the following options: